New NSAIDs-NO hybrid molecules with antiproliferative properties on human prostatic cancer cell lines

Bioorg Med Chem Lett. 2008 Aug 15;18(16):4655-7. doi: 10.1016/j.bmcl.2008.07.018. Epub 2008 Jul 10.

Abstract

The design of profen hybrids containing a NO donor moiety connected to an aliphatic spacer led to compounds with a similar cyclooxygenase inhibition compared to their parent profen and with significant antiproliferative activities on PC3 cells. However, inhibition of COX-2 pathway alone did not seem sufficient to inhibit cancer cell proliferation, and NO-release in a time-dependent manner strongly contributes to this activity.

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / chemical synthesis*
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Cell Proliferation
  • Chemistry, Pharmaceutical / methods*
  • Cyclooxygenase 1 / metabolism
  • Cyclooxygenase 2 / metabolism
  • Cyclooxygenase Inhibitors / pharmacology
  • Drug Design
  • Humans
  • Inhibitory Concentration 50
  • Male
  • Models, Chemical
  • Nitric Oxide / chemistry*
  • Prostatic Neoplasms / drug therapy*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antineoplastic Agents
  • Cyclooxygenase Inhibitors
  • Nitric Oxide
  • Cyclooxygenase 1
  • Cyclooxygenase 2